Oculomotor control in asymptomatic and recently diagnosed individuals with the genetic marker for Huntington's disease.
about
Ocular motor abnormalities in neurodegenerative disordersMotor onset and diagnosis in Huntington disease using the diagnostic confidence level.Motor decline in clinically presymptomatic spinocerebellar ataxia type 2 gene carriers.Visual scanning and cognitive performance in prediagnostic and early-stage Huntington's disease.Progression in prediagnostic Huntington disease.Multiple step pattern as a biomarker in Parkinson diseaseAssessment of motor symptoms and functional impact in prodromal and early huntington diseaseDifferential loss of thalamostriatal and corticostriatal input to striatal projection neuron types prior to overt motor symptoms in the Q140 knock-in mouse model of Huntington's disease.Abnormal error-related antisaccade activation in premanifest and early manifest Huntington disease.Reflexive and volitional saccades: biomarkers of Huntington disease severity and progressionThe antisaccade task as a research tool in psychopathology: a critical review.Behavioral measures of saccade latency and inhibition in manifest and premanifest Huntington's disease.An Open-label, Self-control, Prospective Study on Cognitive Function, Academic Performance, and Tolerability of Osmotic-release Oral System Methylphenidate in Children with Attention-deficit Hyperactivity Disorder.Comparison of vertical and horizontal saccade measures and their relation to gray matter changes in premanifest and manifest Huntington disease.Loss of corticostriatal and thalamostriatal synaptic terminals precedes striatal projection neuron pathology in heterozygous Q140 Huntington's disease mice.Neurophysiology and neuroanatomy of reflexive and volitional saccades: evidence from studies of humans.Quantitative meta-analysis of fMRI and PET studies reveals consistent activation in fronto-striatal-parietal regions and cerebellum during antisaccades and prosaccadesPathologic correlates of supranuclear gaze palsy with parkinsonism.Cholinergic interneurons in the Q140 knockin mouse model of Huntington's disease: Reductions in dendritic branching and thalamostriatal input.Scanning Patterns of Faces do not Explain Impaired Emotion Recognition in Huntington Disease: Evidence for a High Level MechanismVoluntary saccade inhibition deficits correlate with extended white-matter cortico-basal atrophy in Huntington's disease.Neural activity in primate caudate nucleus associated with pro- and antisaccades.The impact of oculomotor functioning on neuropsychological performance in Huntington disease.Using Saccadometry with Deep Brain Stimulation to Study Normal and Pathological Brain Function.Disrupted striatal neuron inputs and outputs in Huntington's disease.Premanifest Huntington's disease: Examination of oculomotor abnormalities in clinical practice.Vergence and Strabismus in Neurodegenerative Disorders.Quantifying Motor Impairment in Movement Disorders.
P2860
Q27021983-B0D6D4C7-838D-4A16-90FF-BAFC57C99DF0Q30684587-CCA3473B-25F6-4221-87FF-A7F996044EFAQ33436218-B94CD789-97D5-4F92-9881-D88B4C0C5F5EQ33709738-108EAC0B-6D39-4403-B1AC-901C95883EC3Q33861265-69528844-ABE8-44D8-B6F8-9B884D790650Q33862099-947B3B26-49F5-4582-9EAC-EFE08C72330FQ33976556-1C470C86-857A-4CD9-9342-121F7D465E8FQ34341619-15C30083-4806-4975-A75D-4CB441BAEAFFQ34917383-D8DFB84B-3C44-4F8F-8A23-F4616BA64CD3Q35663482-41C67FF0-5B57-447F-B623-2FF0577A11CBQ36522001-45BECCE2-6073-4F47-8B21-13A3A2339295Q36600048-748A63C2-8D4C-434E-89D5-D41F03CD5790Q36695980-BAB69A56-F132-4794-A50B-0BEA11E55605Q36988659-1BE8753B-4BEE-4BCE-8471-407DB52975D9Q37255018-EDA4D37F-FC94-4290-9B9C-0A205076D9F9Q37286739-F7765F96-A0CE-44AC-8675-945330D63126Q38153689-68822AB9-7056-4B78-B85B-9F84F8EAC5D3Q38931415-BAF47B4E-ACB7-423F-8AD9-96301D0ABC5BQ39740166-BF6ABB54-0BD7-45EB-B271-9B75007481FFQ41169433-B3D46630-CFA4-44B9-9062-7FBC512E120BQ42176734-3A248BA0-F7FB-482A-A635-C110CC288059Q42458708-46E430D9-0AC9-44E7-82E5-D5C09131F316Q45292458-72650765-5E7E-42A0-AC7A-7EAFB5E52372Q48582905-1D4C65F3-054F-4190-B83F-5AF397D14AFDQ52690256-73D1311C-9190-4F56-9006-A4BED5135A8CQ55024002-B9429677-E3A1-4626-A6A4-09835EB1F9EBQ55093132-B7E4E6C3-F71F-4635-BD08-215395562291Q55244629-A1239BA4-A56A-4AF4-A68E-E0FEE76DB2D1
P2860
Oculomotor control in asymptomatic and recently diagnosed individuals with the genetic marker for Huntington's disease.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Oculomotor control in asymptom ...... rker for Huntington's disease.
@en
Oculomotor control in asymptom ...... rker for Huntington's disease.
@nl
type
label
Oculomotor control in asymptom ...... rker for Huntington's disease.
@en
Oculomotor control in asymptom ...... rker for Huntington's disease.
@nl
prefLabel
Oculomotor control in asymptom ...... rker for Huntington's disease.
@en
Oculomotor control in asymptom ...... rker for Huntington's disease.
@nl
P2093
P1433
P1476
Oculomotor control in asymptom ...... arker for Huntington's disease
@en
P2093
P304
P356
10.1016/J.VISRES.2004.06.006
P577
2004-10-01T00:00:00Z